Faeth Therapeutics
Senior Medical Director
San Francisco, CA, USA
Faeth Therapeutics
Acquisition
Categories
Founded
2022
Leadership
- Anand Parikh, JD, Co-Founder and CEO
Headquarters
San Francisco, CA
Website
S2G North Star Interim Outcomes
- Increased availability, accessibility, and/or affordability of healthier foods and nutrition-based solutions Jump to footnote 1
Faeth is a data-driven, evidence-based company with a deep mechanistic understanding of the way that nutrients influence tumor growth and cancer treatment.
The company’s discovery platform matches tumor genotypes with treatment regimens combining therapeutic targets and precision metabolic optimization to improve patient outcomes.
Open Positions
-
-
Faeth Therapeutics
Director/Senior Director, FP&A
San Francisco, CA, USA -
Faeth Therapeutics
Clinical Data Manager
San Francisco, CA, USA -
Faeth Therapeutics
Kitchen Manager/Executive Chef
Denver, CO, USA -
Faeth Therapeutics
HR Lead
San Francisco, CA, USA
Insights
News
Inside Precision Medicine
Faeth Therapeutics Proves Three-Pronged Approach to Cancer, Preclinically
Footnotes
S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.